OR WAIT null SECS
BioOutsource will expand its US presence, opening a new laboratory facility in Massachusetts to support the company's biosimilar and biosafety service offerings.
Scotland-based BioOutsource has announced that the company will expand its US presence, opening a new laboratory facility in Massachusetts in 2015 to support and strengthen the company’s biosimilar and biosafety service offerings.
The company, a biologics contract testing and biosimilar characterization organization, opened its first US office in 2013 in Cambridge, Mass. The company plans to open the new laboratory facility in early 2015 to service their North American and Latin American clients.
BioOutsource announced that the last 12 months have been an exceptional growth year for the company. The company has grown by more than 40%, with positive growth delivered across all business units.